Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Bright Changyou probiotic flavored yogurt
BRIGHT MINDS BIOSCIENCES INC.
Intestinal Health
1 trial -
Bundle Group 1 with Nutrilite Lifestyle
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial -
Cadonilimab
The First People's Hospital of Lianyungang
Locally Advanced Esophageal Squamous Cell Carcinoma
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Combination group
Hospital Authority, Hong Kong
Cardiac Arrest
1 trial -
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Contrast-enhanced ultrasound-guided core biopsy
The First People's Hospital of Lianyungang
Pancreatic Disease
1 trial -
Controlled low central venous pressure (CLCVP) technology
The First People's Hospital of Lianyungang
Acute Kidney Injury
1 trial -
Cytoxan
shifeng Lou
Hemophagocytic Syndrome
1 trial -
Dapagliflozin Treatment Group
The First People's Hospital of Lianyungang
Atrial Fibrillation (AF)
1 trial -
Dexmedetomidine
Shiyou Wei
Lung Cancer
1 trial -
Dexmedetomidine group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonoscopy
1 trial -
Diaphragmatic Ultrasound
Hospital Authority, Hong Kong
Diaphragmatic Paralysis
1 trial -
ESC 0/1 hour troponin pathway
NORTHWEST BIOTHERAPEUTICS INC
Acute Coronary Syndrome
1 trial -
ET-01
Guangzhou Virotech Pharmaceutical Co.,
Transfusion Dependent Beta-Thalassaemia
1 trial -
Efgartigimod + Telitacicept (1-week interval) group
The First People's Hospital of Lianyungang
Myasthenia Gravis
1 trial -
Esketamine-lidocaine group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Chronic Pain
1 trial -
Exparel block in arthroscopic shoulder surgery
Pacira Ireland Limited
Injury of Shoulder Region
1 trial -
Experimental group
The First People's Hospital of Lianyungang
Overweight or Obesity
1 trial -
External beam radiotherapy
International Peace Maternity and Child Health Hospital
Squamous Cell Carcinoma of the Head and Neck
1 trial -
Febuxostat
The First People's Hospital of Lianyungang
Refractory Gout
1 trial -
Ferrous Fumarate Oral Tablet
Hospital Authority, Hong Kong
Iron Deficiency Anemia Treatment
1 trial -
GD007 Low-dose drug group
The First People's Hospital of Lianyungang
Moderate-Severe Intrauterine Adhesions
1 trial -
GE Logiq E10 clinical ultrasound scanner
United Therapeutics Europe Ltd
Breast Tumor
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources